Early switch from run-in with targeted to immunotherapy in advanced BRAFV600-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial
by Livingstone, Elisabeth (Author)
, Gogas, H. J. (Author)
, Kandolf, L. (Author)
, Meier, F. (Author)
, Eigentler, T. K. (Author)
, Ziemer, M. (Author)
, Terheyden, P. (Author)
, Gesierich, A. (Author)
, Herbst, R. A. (Author)
, Kähler, K. C. (Author)
, Ziogas, D. C. (Author)
, Mijušković, Ž. (Author)
, Garzarolli, M. (Author)
, Garbe, C. (Author)
, Roesch, A. (Author)
, Ugurel, S. (Author)
, Gutzmer, R. (Author)
, Gaudy-Marqueste, C. (Author)
, Kiecker, F. (Author)
, Utikal, Jochen (Author)
, Hartmann, M. (Author)
, Miethe, S. (Author)
, Eckhardt, S. (Author)
, Zimmer, L. (Author)
, Schadendorf, Dirk (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource